Literature DB >> 7882397

Infrainguinal directional atherectomy: long-term follow-up and comparison with percutaneous transluminal angioplasty.

P M Wildenhain1, M H Wholey, C R Jarmolowski, K L Hill.   

Abstract

PURPOSE: To assess the long-term results of directional atherectomy (DA) for femoropopliteal artery atherosclerotic lesions and to compare the results to those previously reported for percutaneous transluminal balloon angioplasty (PTA).
MATERIALS AND METHODS: Eight-four percutaneous DA procedures performed on 75 patients between July 1988 and August 1992 were retrospectively reviewed and evaluated for technical and initial clinical success. Long-term patency was assessed with a combination of ankle-brachial index measurements and angiography.
RESULTS: Initial technical success was achieved in 77 of 84 procedures (92%). Follow-up of 72 patients was obtained, including 74 of the 84 (88%) DA procedures with a mean follow-up of 17.4 months (range 1-48 months). Primary patency was 78% at 1 year and 57% at 2 years. Patients with diabetes, complete luminal occlusion, or limb salvage situations had significantly lower patency.
CONCLUSIONS: Femoropopliteal artery DA can be performed safely with a high technical and initial clinical success. Long-term patency is improved when compared with published series for PTA. With this improvement in mind, DA may have a place in the treatment of focal infrainguinal stenoses.

Entities:  

Mesh:

Year:  1994        PMID: 7882397     DOI: 10.1007/bf00203948

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  18 in total

1.  Standards for evaluating results of interventional therapy for peripheral vascular disease.

Authors:  R B Rutherford
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

2.  Removal of focal atheromatous lesions by angioscopically guided high-speed rotary atherectomy. Preliminary experimental observations.

Authors:  S S Ahn; D Auth; D R Marcus; W S Moore
Journal:  J Vasc Surg       Date:  1988-02       Impact factor: 4.268

3.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  L Schwartz; M G Bourassa; J Lespérance; H E Aldridge; F Kazim; V A Salvatori; M Henderson; R Bonan; P R David
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

4.  Simpson catheter for percutaneous transluminal removal of atheroma.

Authors:  D E Schwarten; B T Katzen; J B Simpson; W B Cutcliff
Journal:  AJR Am J Roentgenol       Date:  1988-04       Impact factor: 3.959

5.  Long-segment femoropopliteal stenoses: is angioplasty a boon or a bust?

Authors:  R R Murray; R C Hewes; R I White; S E Mitchell; M Auster; R Chang; S Kadir; M L Kinnison; S L Kaufman
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

6.  Acute effects of transluminal angioplasty in three experimental models of atherosclerosis.

Authors:  D P Faxon; V J Weber; C Haudenschild; S B Gottsman; W A McGovern; T J Ryan
Journal:  Arteriosclerosis       Date:  1982 Mar-Apr

7.  5-year results of a prospective study of percutaneous transluminal angioplasty.

Authors:  K W Johnston; M Rae; S A Hogg-Johnston; R F Colapinto; P M Walker; R J Baird; K W Sniderman; P Kalman
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

Review 8.  "Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters"--the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment.

Authors:  B F Waller
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  2 in total

1.  Evaluation of the pullback atherectomy catheter in the treatment of lower limb vascular disease.

Authors:  S Grubnic; S D Heenan; T M Buckenham; A M Belli
Journal:  Cardiovasc Intervent Radiol       Date:  1996 May-Jun       Impact factor: 2.740

2.  Is atherectomy the best first-line therapy for limb salvage in patients with critical limb ischemia?

Authors:  Gabriel Loor; Christopher L Skelly; Carl-Magnus Wahlgren; Hisham S Bassiouny; Giancarlo Piano; Wael Shaalan; Tina R Desai
Journal:  Vasc Endovascular Surg       Date:  2009-07-29       Impact factor: 1.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.